Cachet Pharmaceutical Co Ltd
SZSE:002462
Relative Value
The Relative Value of one Cachet Pharmaceutical Co Ltd stock under the Base Case scenario is 44.85 CNY. Compared to the current market price of 15.61 CNY, Cachet Pharmaceutical Co Ltd is Undervalued by 65%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
Competitors Multiples
Cachet Pharmaceutical Co Ltd Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CN |
C
|
Cachet Pharmaceutical Co Ltd
SZSE:002462
|
4.6B CNY | 0.2 | 64.1 | 14 | 14 | |
| US |
|
Mckesson Corp
NYSE:MCK
|
120B USD | 0.3 | 27.6 | 19.5 | 21.9 | |
| US |
A
|
Amerisourcebergen Corp
LSE:0HF3
|
70.9B USD | 0.2 | 43.8 | 15.4 | 19.4 | |
| US |
|
Cencora Inc
NYSE:COR
|
71.1B USD | 0.2 | 43.8 | 15.4 | 19.4 | |
| US |
|
Cardinal Health Inc
NYSE:CAH
|
53.6B USD | 0.2 | 32.2 | 15.5 | 20.1 | |
| AU |
|
Sigma Healthcare Ltd
ASX:SIG
|
32.8B AUD | 5.5 | 62.2 | 47 | 47 | |
| US |
|
Henry Schein Inc
NASDAQ:HSIC
|
9.7B USD | 0.7 | 24.6 | 11.7 | 16.3 | |
| CN |
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
63.9B CNY | 0.2 | 11.3 | 15.2 | 15.2 | |
| CN |
|
Huadong Medicine Co Ltd
SZSE:000963
|
62.7B CNY | 1.5 | 16.9 | 13.1 | 13.1 | |
| CN |
|
Sinopharm Group Co Ltd
HKEX:1099
|
66.1B HKD | 0.1 | 8.5 | 1.5 | 2 | |
| KR |
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
12.2T KRW | 5.9 | 89.6 | 59.9 | 61.9 |